Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · Real-Time Price · USD
19.34
-1.10 (-5.38%)
At close: Mar 6, 2026, 4:00 PM EST
19.02
-0.32 (-1.65%)
After-hours: Mar 6, 2026, 7:57 PM EST
Amphastar Pharmaceuticals Employees
Amphastar Pharmaceuticals had 1,976 employees as of December 31, 2025. The number of employees decreased by 52 or -2.56% compared to the previous year.
Employees
1,976
Change (1Y)
-52
Growth (1Y)
-2.56%
Revenue / Employee
$364,315
Profits / Employee
$49,643
Market Cap
877.46M
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Perrigo Company | 8,379 |
| Evotec SE | 4,788 |
| Tilray Brands | 2,842 |
| Alvotech | 1,012 |
| Pacira BioSciences | 790 |
| Cronos Group | 459 |
| Collegium Pharmaceutical | 423 |
| Harrow | 382 |
AMPH News
- 2 days ago - Amphastar Pharmaceuticals to Present at the Barclays 28th Annual Global Healthcare Conference - Accesswire
- 6 days ago - Amphastar: Higher Costs, Lower Growth, And A 'Value Trap' Label - Seeking Alpha
- 8 days ago - Amphastar Pharmaceuticals, Inc. (AMPH) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2025 - Accesswire
- 10 days ago - Amphastar Announces FDA Approval for Ipratropium Bromide HFA - Accesswire
- 14 days ago - Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 26, 2026 - Accesswire
- 7 weeks ago - Amphastar Pharmaceuticals, Inc. (AMPH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 7 weeks ago - Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthetic Corticotropin Compound - Accesswire